Systematic review and meta-analysis finds high prevalence of ocular manifestations in leukemia patients
This systematic review and meta-analysis evaluated the prevalence of ocular manifestations in patients with leukemia, including 1016 patients across included studies. The primary outcome was overall ocular manifestations, with a pooled prevalence of 42% (logit event rate: -0.3307; 95% CI: -0.456 to -0.206; P < 0.0001). Secondary outcomes included retinal hemorrhage (13%-15%), retinal infiltration (3%), and retinal vein occlusion (1.2%). The analysis for retinal infiltration showed low heterogeneity (I^2 = 10.2%), while retinal vein occlusion had no heterogeneity (I^2 = 0%).
The authors note an association between retinal vein occlusion and leukemia, but caution that this is not necessarily causal. Limitations of the meta-analysis were not explicitly reported, but the findings are based on pooled observational data. The authors emphasize the importance of routine ophthalmic screening, including fundus examination, OCT, and OCTA, as integral components of leukemia management.
For clinicians, this review highlights that ocular involvement is common in leukemia and may be underrecognized. While the evidence is observational, the high prevalence supports a low threshold for ophthalmologic evaluation in patients with leukemia. Further research is needed to clarify the clinical impact of screening on outcomes.